Pallas Capital Advisors’s Picard Medical PMI Stock Holding History

Pallas Capital Advisors’s Portfolio PMI Stock Details PMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.95K	Buy	+1,095	New	+$23.3K	﹤0.01%	1026

Other funds holding PMI

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Parcion Private Wealth Bellevue, Washington $1.8B AUM 30.57% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Pallas Capital Advisors's PMI Position: Q2 2026 in Review

Pallas Capital Advisors opened a new position in Picard Medical (PMI) in Q2 2026: 1,095 shares worth $8.95K. The stake represents ﹤0.01% of the portfolio and ranks #1026 among its holdings.

16 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

Pallas Capital Advisors held 1,095 shares of Picard Medical worth $8.95K as of Q2 2026.
Picard Medical was a new Pallas Capital Advisors position in Q2 2026.
Picard Medical made up ﹤0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #1026 holding.
16 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.